Evolus, Inc.

EOLS chart

Evolus, Inc. news

• Soleus Capital Discloses 7.7% Ownership Stake in Evolus as of September 30, 2026

  Kalkine Media · Nov 9, 10:33 PM EST

• Evolus, Inc. News — LSE:0K16

  TradingView · Nov 9, 1:51 AM EST

• Evolus, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:EOLS) 2026-11-07

  Seeking Alpha · Nov 7, 6:36 PM EST

• Evolus, Inc. (EOLS) Seasonal returns chart

  Yahoo Finance UK · Nov 7, 5:39 PM EST

• Evolus grants 115,000 RSUs to new hires under Nasdaq rule

  scanx.trade · Nov 7, 11:50 AM EST

• A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $13 to $20

  Moomoo · Nov 6, 8:00 AM EST

• Evolus, Inc. (EOLS) stock price, news, quote and history

  Yahoo Finance Australia · Nov 5, 9:55 PM EST

• Evolus faces investigation after FDA flags misl...

  Pluang · Nov 5, 8:06 PM EST

• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS

  PR Newswire · Nov 5, 7:42 PM EST

• Evolus Inc (EVL.SG) Seasonal returns chart

  Yahoo Finance UK · Nov 5, 4:44 PM EST

• How Did Evolus (NASDAQ:EOLS) Cut Its Net Loss to USD 12.5 Million on 13.0% Growth?

  kalkine.ca · Nov 5, 12:41 PM EST

• Evolus (EOLS) Q3 2026 Earnings Call Transcript

  fool.com · Nov 5, 11:28 AM EST

Evolus, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-04
• 8-K8-K2026-11-04
• 10-Q10-Q2026-08-05
• 8-K8-K2026-08-05
• 8-K8-K2026-08-04
• 8-K8-K2026-07-08
• 8-K8-K2026-06-12
• 10-Q10-Q2026-05-04
• 8-K8-K2026-05-04
• DEF 14ADEF 14A2026-04-29
• 8-K8-K2026-03-13
• 10-K10-K2026-03-03

About Evolus, Inc.

Ticker

EOLS (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Newport Beach, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1570562

Former names

Evolus, Inc.

Frequently asked questions